Skip to content

Reduction of ventilation invasiveness through combined organ support

Reduction of ventilation invasiveness through combined organ support - ADVOVENT (Advanced organ support for reduction of ventilation invasiveness)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015874
Enrollment
10
Registered
2018-11-13
Start date
2018-11-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J96 N17

Interventions

Group 1: removal of carbon dioxide (CO2) and correction of acidosis via ADVOS treatment

Sponsors

Universitätsklinikum Schleswig-Holstein
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - invasive controlled ventilation at acute hypercapnic respiratory failure (PaCO2 > 45 mmHg) - tidal volume > 6ml/kg ideal weight or driving pressure difference (delta p) > 15 cmH2O required to reach a pH value > 7,30 - acute renal failure (KDIGO II or III) - clinical indication for continuous venovenous haemodialysis - consent to participate in the clinical trial

Exclusion criteria

Exclusion criteria: - severe acute hypoxemic respiratory failure (PaO2/FiO2 ratio 150 bpm or mean arterial pressure < 65 mmHg or cardiac output < 5 l/min despite adequate therapy) - elevated intracranial pressure

Design outcomes

Primary

MeasureTime frame
Tidal volume (ml/kg ideal weight) to reach a ventilation with a pH value >7,30 and PaCO2 < 60 mmHg (measured 6 hours after the beginning of the ADVOS treatment)

Secondary

MeasureTime frame
- CO2 removal achieved with the ADVOS system (ml/min) - required alveolar ventilation per minute (l/min) - pressure difference between airway plateau pressure and PEEP (cmH2O) - change of power of ventilation (Joule/min) - partial pressure of oxygen (mmHg) - partial pressure of carbon dioxide (mmHg) - pH

Countries

Germany

Contacts

Public ContactLars Hummitzsch

Klinik für Anästhesiologie und operative Intensivmedizin, Universtitätsklinikum Schleswig Holstein, Campus Kiel

Lars.Hummitzsch@uksh.de043150020801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026